Sterling Capital Management LLC Intra Cellular Therapies, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 1,870 shares of ITCI stock, worth $164,971. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,870Holding current value
$164,971% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
399Shares Held
88.4MCall Options Held
365KPut Options Held
306K-
Vanguard Group Inc Valley Forge, PA9.63MShares$849 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$558 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$466 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$340 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$269 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.33B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...